|
⚲
|
| Mediquest Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001263358 |
| Sale | 2009-05-20 ($15.0 M Offered, $2.3 M Sold) |
| Fund | |
| Phone | 4253989580 |
| Address | 22322 20th Avenue SE Bothell, 98021 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Jeffrey Gregory | |
| Joseph Piper | |
| Hans Lundin | |
| Frederick Dechow | |
| T Ellison | |
| Thomas Dooley | |
| Julia Brown | |
| Carol Danielson | |
| Sinclair Dunlop |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Owl Ventures, L.P.
✚
|
0.0 | |
|
OWS CF B LLC
✚
|
0.0 | |
|
OWYN SPV LLC
✚
|
0.0 | |
|
Oxbow EP, LLC
✚
|
0.0 | |
|
Oxeia Biopharmaceuticals, Inc.
✚
|
0.0 | |
|
Oxer Mezzanine Fund III, L.P.
✚
|
0.0 | |
|
Ahearn Robin N.
✚
|
0.0 | |
|
AH Grand Rapids Investors LLC
✚
|
0.0 | |
|
AHL Alpha (Cayman) Ltd
✚
|
0.0 | |
|
OWL ESG Dec 2022 a Series of CGF2021 LLC
✚
|
0.0 |